145 related articles for article (PubMed ID: 23745949)
21. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
22. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
23. Performance and Sensitivity of [
Hernández-Lozano I; Leterrier S; Mairinger S; Stanek J; Zacher AS; Breyer L; Hacker M; Zeitlinger M; Pahnke J; Tournier N; Wanek T; Langer O
Mol Pharm; 2024 Feb; 21(2):932-943. PubMed ID: 38225758
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart.
Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
Circulation; 1990 Sep; 82(3):998-1007. PubMed ID: 2394016
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression in pituitary adenoma.
Kunishio K; Okada M; Matsumoto Y; Nagao S; Nishiyama Y
J Med Invest; 2006 Aug; 53(3-4):285-91. PubMed ID: 16953066
[TBL] [Abstract][Full Text] [Related]
28. 99mTc-MIBI imaging of cutaneous AIDS-associated Kaposi's sarcoma.
Peer FI; Pui MH; Mosam A; Rae WI
Int J Dermatol; 2007 Feb; 46(2):166-71. PubMed ID: 17269969
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
Zhang XM; Zhang ZW; Wu H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
[TBL] [Abstract][Full Text] [Related]
30. Does the Clearance of Inhaled (99m)Tc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung?
Mohan HK; Routledge T; Cane P; Livieratos L; Ballinger JR; Peters AM
Radiology; 2016 Sep; 280(3):924-30. PubMed ID: 26954010
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
Belhaj-Tayeb H; Briane D; Vergote J; Kothan S; Léger G; Bendada SE; Tofighi M; Tamgac F; Cao A; Moretti JL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):502-9. PubMed ID: 12536243
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Value of Semiquantitative Analysis of 99mTechnetium-Methoxyisobutylisonitrile (99mTc-MIBI) Imaging in Predicting Early-Stage Cervical Lymph Node Metastasis of Thyroid Carcinoma.
Zhu XC; Zhou K; Xu SQ; Ma YB
Med Sci Monit; 2017 Mar; 23():1552-1558. PubMed ID: 28362720
[TBL] [Abstract][Full Text] [Related]
33. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
Tatsumi M; Tsuruo T; Nishimura T
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701
[TBL] [Abstract][Full Text] [Related]
35. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
36. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
[TBL] [Abstract][Full Text] [Related]
37. Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans.
Savi A; Gerundini P; Zoli P; Maffioli L; Compierchio A; Colombo F; Matarrese M; Deutsch E
Eur J Nucl Med; 1989; 15(9):597-600. PubMed ID: 2598955
[TBL] [Abstract][Full Text] [Related]
38. Dobutamine modulated Tc-99m MIBI scintigraphy in secondary hyperparathyroidism in uremic patients.
Quagliata A; López JJ; Guissoli P; Gambini JP; Hermida JC; Alonso O
Clin Nucl Med; 2007 Oct; 32(10):782-6. PubMed ID: 17885358
[TBL] [Abstract][Full Text] [Related]
39. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]